Charles River Laboratories International

CRL

NYSEHealth Care

Income Statement

Total Revenue$4.05B

Gross Profit$1.33B

Operating Income$227.35M

EBITDA$578.06M

EBIT$216.31M

Pre-tax Income$-165.42M

Net Income$22.2M

Cash Equivalent$227.76M

Total Debt$2.85B

Book Value$3.7B

Book Value Per Share72.04

Return on Equity (ROE)+30.00%

Return on Assets (ROA)+14.00%

Return on Invested Capital (ROI)+18.00%

Net Profit Margin+25.00%

Current Ratio1.41

Quick Ratio0.94

Long-Term Debt / Equity0.64